Outcomes of coronavirus disease 19 patients with a history of rheumatoid arthritis: A retrospective registry-based study in Iran.
Mahsa ZargaranShafieh MovassaghiMonireh Sadat SeyyedsalehiKazem ZendehdelAbdolrahman RostamianPublished in: International journal of rheumatic diseases (2022)
The risk of COVID-19 outcomes was higher in RA patients than non-RA patients, especially for RA patients who received a low dose of prednisolone. The results of this study can be used to triage RA patients who get infected by COVID-19. Further studies with larger sample sizes are required to more precisely define the high-risk groups.
Keyphrases
- rheumatoid arthritis
- coronavirus disease
- end stage renal disease
- low dose
- disease activity
- sars cov
- ejection fraction
- chronic kidney disease
- newly diagnosed
- ankylosing spondylitis
- peritoneal dialysis
- prognostic factors
- interstitial lung disease
- high dose
- patient reported outcomes
- respiratory syndrome coronavirus
- systemic sclerosis
- type diabetes